CVS Dropped From Watchlist as Intel CEO Makes Bold Move
CNBC's Investing Club cuts CVS from its Bullpen watchlist. Intel's CEO takes a firm stance worth watching.
The CNBC Investing Club made a decisive call: CVS is out of the Bullpen watchlist. When a team of professional market watchers stops tracking a stock, that's a signal you shouldn't ignore. It doesn't mean you sell everything tomorrow, but it does mean the conviction behind adding it to a portfolio has faded — and that matters.
The Bullpen is where stocks sit when they're not quite ready for a full buy rating but are worth monitoring closely. Getting kicked out of that tier is a step down, not a lateral move. CVS has been battling a rough stretch — rising costs, shifting pharmacy dynamics, and pressure on its insurance unit have all weighed on the name. Apparently, those headwinds were enough to pull the plug on the watchlist spot entirely.
Read more iShares S&P 500 Growth ETF Added $207M Thursday, NVIDIA on Top →
Meanwhile, Intel's CEO is making a stand. Leadership tone at a turnaround company is everything. Investors in Intel know the stock has been a painful hold, and any sign that management is drawing a line in the sand on strategy or execution deserves a close look. Whether this is a genuine inflection point or just noise is the question you need to answer before touching the stock.
Both moves came through CNBC's Investing Club Homestretch, the actionable afternoon update designed to get members positioned ahead of the final hour of trading. That closing hour is when institutional players adjust exposure — and being early to these calls can make a real difference in your entry price.
If you're running a watchlist of your own, the CVS cut is a reminder to audit names that have been sitting idle without a clear catalyst. Dead weight on a watchlist becomes dead weight in a portfolio. Continue reading at CNBC.